Related Experiment Video
Updated: Jan 13, 2026

Exploring m6A and m5C Epitranscriptomes upon Viral Infection: an Example with HIV
Published on: March 5, 2022
m6A RNA methylation modulates antiviral response in celiac disease
Maialen Sebastian-delaCruz1,2, Ane Olazagoitia-Garmendia1,2, Izei Pascual-Gonzalez1,2
1University of the Basque Country (UPV-EHU), Leioa, Spain.
Abstract:
N6-methyladenosine (m6A) RNA modifications and reovirus infections have recently been implicated in the development of celiac disease. While viral infections are known to alter the RNA modification machinery of the host, their interplay in autoimmune tissue damage remains unexplored. In this study we employed an in vitro model combining a viral mimic with gliadin peptides to simulate celiac disease conditions, alongside the analysis of serum and intestinal biopsies from controls and patients to investigate the link between m6A methylation and viral infections in inducing autoimmune inflammation. We found elevated anti-reovirus reactivity in patients, increased antiviral gene expression and enhanced m6A levels. Notably, the expression of IRF7 was synergistically induced by the combined exposure to the viral mimic and gliadin peptides, and this is mediated through m6A methylation in its coding region and interaction with the reader protein YTHDC2. Furthermore, the reduction of m6A through METTL3 silencing or simvastatin treatment reduced IRF7 mRNA methylation and downstream proinflammatory gene expression both in vitro and ex vivo. These findings highlight m6A methylation as a modulator of antiviral responses and a potential therapeutic target in autoimmune disorders.
Insights
N6-methyladenosine (m6A) RNA modifications and reovirus infections are linked to celiac disease. This study shows m6A methylation regulates antiviral responses and inflammation, offering a potential therapeutic target for autoimmune disorders.
Area of Science:
- Immunology
- Molecular Biology
- Gastroenterology
Background:
- Celiac disease involves autoimmune tissue damage, with N6-methyladenosine (m6A) RNA modifications and reovirus infections emerging as potential contributors.
- The interplay between viral infections, RNA modification machinery, and autoimmune pathogenesis is not well understood.
Purpose of the Study:
- To investigate the link between m6A methylation, viral infections, and autoimmune inflammation in celiac disease.
- To explore the role of m6A in regulating antiviral gene expression and its potential as a therapeutic target.
Main Methods:
- Utilized an in vitro model with a viral mimic and gliadin peptides to simulate celiac disease conditions.
- Analyzed serum and intestinal biopsies from celiac disease patients and controls.
- Investigated the expression of IRF7 and its regulation by m6A methylation and YTHDC2.
Main Results:
- Patients showed elevated anti-reovirus reactivity, increased antiviral gene expression, and enhanced m6A levels.
- Combined exposure to viral mimic and gliadin synergistically induced IRF7 expression via m6A methylation and YTHDC2 interaction.
- METTL3 silencing or simvastatin treatment reduced m6A, IRF7 methylation, and pro-inflammatory gene expression.
Conclusions:
- m6A RNA methylation acts as a key modulator of antiviral responses in the context of celiac disease.
- Targeting m6A methylation pathways presents a potential therapeutic strategy for autoimmune disorders like celiac disease.
Related Concept Videos
RNA Editing
Leaky Scanning
MicroRNAs
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Viruses with RNA Genomes
Epigenetic Regulation

